Patents by Inventor Pierre Grognet

Pierre Grognet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies specific of the ?-amyloid peptides and their uses as diagnostic agents or drugs
    Patent number: 8343493
    Abstract: A monoclonal antibody which specifically binds to the N-terminal region of A?8-x peptide, x being included from 11 to 42, and recognizes neither A?1-40 nor A?1-42 and which presents a high affinity with respect to A?8-x peptide, such as determined by an immunological complex formation between the monoclonal antibody and the peptide A?8-x.
    Type: Grant
    Filed: October 24, 2008
    Date of Patent: January 1, 2013
    Assignees: Innogenetics N.V., INSERM (Institut National de la Sante et de la Recherche Medicale), Sanofi
    Inventors: Eugeen VanMechelen, Pierre Grognet, Nicolas Sergeant, Marie Gompel, Andre Delacourte, Luc Buee, Laurent Pradier, Veronique Blanchard-Bregeon
  • ANTIBODIES SPECIFIC OF THE BETA-AMYLOID PEPTIDES AND THEIR USES AS DIAGNOSTIC AGENTS OR DRUGS
    Publication number: 20110059092
    Abstract: The present invention relates to a monoclonal antibody which specifically binds to the N-terminal region of A?8-x peptide, x being comprised from 11 to 42, and recognises neither A?1-40 nor A?1-42 and which presents a high affinity with respect to A?8-x peptide, such as determined by an immunological complex formation between the monoclonal antibody and the peptide A?8-x.
    Type: Application
    Filed: October 24, 2008
    Publication date: March 10, 2011
    Applicants: INNOGENETICS NV, SANOFI-AVENTIS
    Inventors: Eugeen Vanmechelen, Pierre Grognet, Nicolas Sergeant, Marie Gompel, Andre Delacourte, Luc Buee, Laurent Pradier, Veronique Blanchard-bregeon
  • Use of gellable pharmaceutical compositions in periodontology
    Patent number: 6818224
    Abstract: A method is described for preparing a fluid pharmaceutical composition which allows the controlled release of at least one active substance. The method involves mixing a therapeutically effective amount of at least one active substance, from 3 to 55% by weight of phospholipid, from 16 to 72% by weight of pharmaceutically acceptable solvent, and from 4 to 52% by weight of fatty acid. The composition has a property of gelling instantaneously in the presence of an aqueous phase.
    Type: Grant
    Filed: September 17, 2002
    Date of Patent: November 16, 2004
    Assignee: UCB, S.A.
    Inventors: Domenico Fanara, Henri Vranckx, Michel Deleers, Pierre Grognet
  • Use of gellable pharmaceutical compositions in periodontology
    Publication number: 20030199477
    Abstract: The invention concerns the use for treating periodontitis of a fluid pharmaceutical composition for controlled release of at least one active substance comprising: a) a therapeutically efficient amount of at least an active substance; b) 3 to 55 wt. % of phospholipid; c) 16 to 72 wt. % of one or several pharmaceutically acceptable solvents; and d) 4 to 52 wt. % of at least one fatty acid. Said composition is characterised in that it has the property of being gelled instantaneously in the presence of an aqueous phase.
    Type: Application
    Filed: September 19, 2002
    Publication date: October 23, 2003
    Inventors: Domenico Fanara, Henri Vranckx, Michel Deleers, Pierre Grognet
  • Use of pharmaceutical compositions capable of being gelled in periodontology
    Patent number: 6471970
    Abstract: A method is described for preparing a fluid pharmaceutical composition which allows the controlled release of at least one active substance. The method involves mixing a therapeutically effective amount of at least one active substance, from 3 to 55% by weight of phospholipid, from 16 to 72% by weight of pharmaceutically acceptable solvent, and from 4 to 52 % by weight of fatty acid. The composition has a property of gelling instantaneously in the presence of an aqueous phase.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: October 29, 2002
    Assignee: UCB, S.A.
    Inventors: Domenico Fanara, Henri Vranckx, Michel Deleers, Pierre Grognet